The interaction of two monoclonal antibodies (mAbs) with actin has bee
n characterized to map die epitopes defined by these mAbs and to deter
mine the accessibility of these sites in the actin filament (F-actin).
Both mAbs react specifically with actin in radioimmunoassays and West
ern blot assays, and by immunoprecipitation. The location of the epito
pes within the primary structure of actin has been determined using li
mited proteolysis of actin and Western blots, or using immunoprecipita
tion of truncated actin fragments synthesized in a cell free translati
on assay. Both mAbs bind to the C-terminal fragment of actin (residues
68375) produced by chymotrypsin cleavage. One epitope is further loca
lized to a 9.9 kD peptide corresponding to residues 5-93. Therefore, t
he epitope defined by this mAb (2G11.4) lies between residues LyS6g an
d Glu93 of actin. The location of the other epitope was determined by
immunoprecipitation of actin fragments synthesized in vitro. Removal o
f residues 356-365 from the C-terminus of actin completely abolished t
he binding of mAb 4E3.adl. Therefore, this mAb defines an epitope that
involves residues between Trp356 and Ala365. The accessibility of the
se epitopes in native F-actin was determined with solution binding ass
ays and characterized by immunoelectron microscopy. Monoclonal antibod
y 4E3.adl binds strongly to filaments, resulting in bundling or decora
tion of F-actin depending on the valency of the mAb, and indicating th
at the epitope is readily accessible in F-actin. In contrast, mAb 2G11
.4 disrupts F-actin structure, resulting in the formation of an amorph
ous immunoprecipitate. These results place constraints on models of ac
tin filament structure.